RABINOWITZ MICHAEL (Chief Commercial Officer) sold 9.6% of their position (13.32K shares) of ORAMED PHARMACEUTICALS INC. on the open market
Open‑market sale worth $167.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/4/2023ACC: 0001209191-23-000517
Officer· Chief Commercial Officer
Since Aug 2021
-13.32K
Net shares
Net seller
$167.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.43K
Price / share
$13.01
Trade value
$18.54K
% of position
1.0%
1/3/2023
139.47K→138.04K
Common Stock
Direct
Shares
−11.90K
Price / share
$12.49
Trade value
$148.65K
% of position
8.6%
1/3/2023
138.04K→126.14K
Total
Net shares
−13.32K
Net value
-$167.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | S · Sale | −1.43K | $13.01 | $18.54K | 1.0% | 139.47K | 138.04K |
| Common Stock Direct | 1/3/2023 | S · Sale | −11.90K | $12.49 | $148.65K | 8.6% | 138.04K | 126.14K |
| Total | −13.32K | -$167.20K | ||||||
Derivative Transactions0
No derivative transactions reported